The Revised Fibromyalgia Impact Questionnaire (FIQR): validation and psychometric properties
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Introduction: The Fibromyalgia Impact Questionnaire (FIQ) is a commonly used instrument in the evaluation of fibromyalgia (FM) patients. Over the last 18 years, since the publication of the original FIQ, several deficiencies have become apparent and the cumbersome scoring algorithm has been a barrier to widespread clinical use. The aim of this paper is to describe and validate a revised version of the FIQ: the FIQR. Methods: The FIQR was developed in response to known deficiencies of the FIQ with the help of a patient focus group. The FIQR has the same 3 domains as the FIQ (that is, function, overall impact and symptoms). It differs from the FIQ in having modified function questions and the inclusion of questions on memory, tenderness, balance and environmental sensitivity. All questions are graded on a 0–10 numeric scale. The FIQR was administered online and the results were compared to the same patient's online responses to the 36-Item Short Form Health Survey (SF-36) and the original FIQ. Results: The FIQR was completed online by 202 FM patients, 51 rheumatoid arthritis (RA) or systemic lupus erythematosus (SLE) patients (31 RA and 20 SLE), 11 patients with major depressive disorder (MDD) and 213 healthy controls (HC). The mean total FIQR score was 56.6 ± 19.9 compared to a total FIQ score of 60.6 ± 17.8 ( P < 0.03). The total scores of the FIQR and FIQ were closely correlated ( r = 0.88, P < 0.001). Each of the 3 domains of the FIQR correlated well with the 3 related FIQ domains ( r = 0.69 to 0.88, P < 0.01). The FIQR showed good correlation with comparable domains in the SF-36, with a multiple regression analysis showing that the three FIQR domain scores predicted the 8 SF-36 subscale scores. The FIQR had good discriminant ability between FM and the 3 other groups; total FIQR scores were HC (12.1 ± 11.6), RA/SLE (28.6 ± 21.2) and MDD (17.3 ± 11.8). The patient completion time was 1.3 minutes; scoring took about 1 minute. Conclusions: The FIQR is an updated version of the FIQ that has good psychometric properties, can be completed in less than 2 minutes and is easy to score. It has scoring characteristics comparable to the original FIQ, making it possible to compare past FIQ results with future FIQR results.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The FIQR is a 21-item, validated self-report instrument that assesses function, overall impact, and symptoms over the past seven days.22”
From Mindfulness is associated with psychological health and moderates the impact of fibromyalgia (2019) · cites this paper as [22]
The cited source says what the claim attributes to it.
In the citing paper
“All the included studies referred to the original version of the FIQ score [46]: the revised version of the FIQ was not used [47].”
From Duloxetine for fibromyalgia syndrome: a systematic review and meta-analysis (2023) · cites this paper as [47]
In the citing paper
“validated clinical questionnaires for FM and IC/BPS”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1992) · PubMed · Cited by 33,716
The MOS 36-ltem Short-Form Health Survey (SF-36): I. Conceptual Framework and Item Selection
Ware, J. E., & Sherbourne, C. D. (1992) · Medical Care · doi:10.1097/00005650-199206000-00002 · Cited by 30,033
The american college of rheumatology 1990 criteria for the classification of fibromyalgia
Wolfe, F., Smythe, H. A., Yunus, M. B., Bennett, R. M., Bombardier, C., Goldenberg, D. L., Tugwell, P., Campbell, S. M., Abeles, M., Clark, P., et al. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330203 · Cited by 9,563
Self-citationInternational Classification of Functioning Disability and Health (ICF)
Battistella, L. R., & Brito, C. M. M. D. (2002) · Acta Fisiátrica · doi:10.5935/0104-7795.20020003 · Cited by 4,446
Core outcome measures for chronic pain clinical trials: IMMPACT recommendations
Dworkin, R. H., Turk, D. C., Farrar, J. T., Haythornthwaite, J. A., Jensen, M. P., Katz, N. P., Kerns, R. D., Stucki, G., Allen, R. R., Bellamy, N., et al. (2005) · Pain · doi:10.1016/j.pain.2004.09.012 · Cited by 3,732 · cited 2×
“Our favorable experience with the use of a numeric rating scale compared to continuous VAS scoring reflects the experience of several other groups [21,22,23] and is in line with the recommendations of the Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT) [24].”
MethodCore outcome domains for chronic pain clinical trials: IMMPACT recommendations
Turk, D. C., Dworkin, R. H., Allen, R. R., Bellamy, N., Brandenburg, N., Carr, D. B., Cleeland, C., Dionne, R., Farrar, J. T., Galer, B. S., et al. (2003) · Pain · doi:10.1016/j.pain.2003.08.001 · Cited by 3,510
(1991) · PubMed · Cited by 1,837
Self-citationAn internet survey of 2,596 people with fibromyalgia
Bennett, R. M., Jones, J., Turk, D. C., Russell, I. J., & Matallana, L. (2007) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-8-27 · Cited by 865 · cited 7×
“Functioning, Disability and Health (ICF) guidelines [8] and patient surveys from the USA [9] and Germany [10].”
BackgroundInfluentialSelf-citationBennett, R. M. (2005) · PubMed · Cited by 623
Self-citationNeurocognitive impairment in drug-free patients with major depressive disorder
Porter, R. J., Gallagher, P., Thompson, J. M., & Young, A. H. (2003) · British Journal of Psychiatry · doi:10.1192/bjp.182.3.214 · Cited by 519 · cited 1×
“The scores on Memory were similar in the FM group and the MDD group, probably an expression of the well documented memory problems associated with depressive illness [18,19].”
Result
Cited by
Items 701–800 of 815
Marcus, D. A., & Deodhar, A. A. (2010) · Springer eBooks · doi:10.1007/978-1-4419-1609-9_15
Measuring Disease Activity and Functional Capacity in Telerheumatology
Richards, J. S. (2022) · Springer eBooks · doi:10.1007/978-3-031-00936-5_11
High Levels of Empathic Concern in Fibromyalgia Patients
Leyton-Hernández, D., & Vales, L. (2022) · Journal of Applied Cognitive Neuroscience · doi:10.17981/jacn.2.2.2021.04
“The Revised Fibromyalgia Impact Questionnaire (FIQR) is an internationally used instrument (Bennett et al., 2009) validated in Spanish (Salgueiro et al.”
BackgroundMethodResultInfluentialVillafaina, S., Llamas, J. L. L., Murillo-García, Á., & Gusi, N. (2022) · Scientific Reports · doi:10.1038/s41598-022-16903-y · Cited by 2
The effects of cold application to trapezius muscle on the fibromyalgia
Kıyak, E. (2022) · Eastern Journal Of Medicine · doi:10.5505/ejm.2022.81904
Hammond, A., Tennant, A., Ching, A., Parker, J. L., Prior, Y., Gignac, M. A. M., Verstappen, S. M. M., & O’Brien, R. (2022) · Research Square · doi:10.21203/rs.3.rs-1744048/v1
Fibromyalgia in the light of different methods of treatment
Szota, M., Modlińska, A., Rogacka, K., & Kędziora–Kornatowska, K. (2022) · Journal of Education Health and Sport · doi:10.12775/jehs.2022.12.12.050
“FIQ jest kwestionariuszem stworzonym przez niemieckich naukowców, który ocenia stan zdrowia fizycznego oraz psychicznego i jest łatwy do oceny [22].”
BackgroundDores crônicas: fibromialgia e lombalgia
Landim, J. I. V. D., Jennings, F., & Domiciano, D. S. (2022) · Revista Paulista de Reumatologia · doi:10.46833/reumatologiasp.2022.21.2.91-97
Medina, S., O’Daly, O., Howard, M. A., Feliu‐Soler, A., & Luciano, J. V. (2023) · Research Square · doi:10.21203/rs.3.rs-2439128/v1
Alptuğ, B., Tüzün, E. H., Keçeci, B., & Eker, L. (2023) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-023-03333-6
Leung, A., Le, V., Lopez, C., Ho, M., Collin, L., Zeynalvand, A., Kim, E., Kim, S. H., & Lee, R. R. (2023) · Research Square · doi:10.21203/rs.3.rs-3290463/v1
Floriano, B. L., da Silva, J. P., Endo, C., & Franco, G. S. (2023) · Brazilian Journal of Development · doi:10.34117/bjdv9n9-075
Saúde e suas novas perspectivas - Volume 04
de Freitas, S. A. A., & Gondim, R. C. D. (2023) · Editora Pascal LTDA eBooks · doi:10.29327/5316885
Fibromialgia: fisiopatología y apoyo terapéutico
Guinot, M., Dumolard, A., & Maindet, C. (2023) · EMC - Kinesiterapia - Medicina Física · doi:10.1016/s1293-2965(23)48360-0
Exercise Training with Fibromyalgia
Batrakoulis, A., Sorace, P., & Mahady, T. P. (2023) · ACSMʼs Health & Fitness Journal · doi:10.1249/fit.0000000000000913 · Cited by 1
Quality of rheumatic care: monitoring and patient-centered care
Beckers, E. (2023) · Research Publications (Maastricht University) · doi:10.26481/dis.20231121eb
Fibromialgia: fisiopatologia e supporto terapeutico
Guinot, M., Dumolard, A., & Maindet, C. (2023) · EMC - Medicina Riabilitativa · doi:10.1016/s1283-078x(23)48503-3
Features of fibromyalgia in patients with rheumatoid arthritis
Melikova, N. A., Filatova, E. G., & Филатова, Е. С. (2024) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202412402128 · Cited by 1
Provan, S. A., Pettersen, P. S., Haugmark, T., Berg, I. J., Hammer, H. B., Neogi, T., Zangi, H. A., & Haugen, I. K. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4821040
AlAujan, S. S., Almalag, H. M., Almazrou, S. H., Alkhudair, N. A., Alodaibi, F., & Omair, M. A. (2024) · Patient Preference and Adherence · doi:10.2147/ppa.s452067 · Cited by 1
Kaban, N., Bakay, U., Soylu, A. C., Gürer, G., & Harman, H. (2024) · Aktuelle Rheumatologie · doi:10.1055/a-2334-6194
“The Revised Fibromyalgia Impact Questionnaire (FIQR) was used to evaluate the total spectrum of fibromyalgia-related problems in both pFMS and pSS with FMS patients [12].”
Cannabis for Fibromyalgia: Hope or Hype?
Yadav, S., Katamesh, B. E., & Vincent, A. (2024) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2024.05.014
Cervical and Ocular Vestibular Evoked Myogenic Potentials in Fibromyalgia Syndrome Patients
Dabbous, A. O., Baki, N. M. A., Hassanein, M. M., & Sheta, S. M. (2024) · The Journal of International Advanced Otology · doi:10.5152/iao.2024.231269
de Souza, S. M. P. (2024) · International Journal of Health Science · doi:10.22533/at.ed.1594792421087
Ponce, F. L., Goicochea, J. L., Rodríguez, D. S., Bravo, E. H., Atanacio, G. O., Macalapú, I. L., Rojas, P. J., & Canani, J. Y. (2024) · Reumatología Clínica · doi:10.1016/j.reuma.2024.06.005
Ponce, F. L., Goicochea, J. L., Rodríguez, D. S., Bravo, E. H., Atanacio, G. O., Macalapú, I. L., Rojas, P. J., & Canani, J. Y. (2024) · Reumatología Clínica (English Edition) · doi:10.1016/j.reumae.2024.10.001
Herrador‐Colmenero, M., Borges‐Cosic, M., Segura‐Jiménez, V., Álvarez‐Gallardo, I. C., Chillón, P., & Delgado‐Fernández, M. (2024) · Healthcare · doi:10.3390/healthcare12212168
“The impact of fibromyalgia on the patients was assessed with the Spanish version of the Revised Fibromyalgia Impact Questionnaire (FIQR), which is a valid tool to discriminate fibromyalgia patients from patient with other diseases [27].”
MethodAlghanim, K. K., Alsaidalani, R., AlSomali, H. F., & Shadi, H. W. E. (2024) · Cureus · doi:10.7759/cureus.72970 · Cited by 1
“…(FIQ) is an extensively validated FM-specific tool that captures the overall effect of FM symptomatology, which was developed by Burckhardt et al. in 1991 and revised in 2009 (FIQR) to address certain shortcomings after 18 years of clinical experience with the original version [11,12].”
Gulati, N., Singh, K., Morrissey, E. J., Calvache, P., Rose-Smith, J., Gore‐Massy, M., Chiu, F., Trinquart, L., Navarro-Millán, I. Y., Folta, S. C., et al. (2025) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2025.101508
Fitzmaurice, B. C., Carroll, J. D., Rayen, A. T. A., Heneghan, N. R., & Soundy, A. (2025) · Clinical and Translational Neuroscience · doi:10.3390/ctn9030029
Fibromyalgia and Primary Care Providers’ Plan of Care
Casseus, K., Cabahug, I. N. K. V., Owusu, B., Atraga, C. F., & Balthazar, M. S. (2025) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2025.105461
Carvalho, C., Vassão, P. G., Santos, T. I. R., Pontes, A. T., de Oliveira, J. G. J., Pinheiro, C. M., Kawabe, M., de Sena, B. P., Pinfildi, C. E., Dourado, V. Z., et al. (2025) · Pain Management · doi:10.1080/17581869.2025.2535272 · Cited by 1
Agostinho, M. R., Emergui, G., Canaipa, R., & Treister, R. (2025) · Journal of Pain · doi:10.1016/j.jpain.2025.105512 · Cited by 1
Symptoms of Fibromyalgia Syndrome have Effects on Pain Grade
Esra, A. K. I. N., Saraçoğlu, İ., & Leblebicier, M. A. (2025) · Physikalische Medizin Rehabilitationsmedizin Kurortmedizin · doi:10.1055/a-2641-9042
Auer, W., Serrat, M., Sanabria‐Mazo, J. P., Royuela-Colomer, E., Pérez‐Aranda, A., Ferrés, S., Robles, B., D’Amico, F., Almirall, M., Cardeñosa, E., et al. (2025) · Journal of Pain · doi:10.1016/j.jpain.2025.105515 · Cited by 2
van den Bosch, O. F. C., van Lennep, J. P. A., Álvarez-Jiménez, R., van Middendorp, H., Evers, A. W. M., Steegers, M. A. H., Schober, P. R., & Loer, S. A. (2025) · Journal of Pain Research · doi:10.2147/jpr.s530506
“17 The total score is calculated by summing individual item responses and is normalized to a 0–100 scale, where higher scores reflect a greater disease burden.”
Amris, K., Rasmussen, M. U., Alkjær, T., Magnúsdóttir, S., & Wæhrens, E. E. (2025) · Scandinavian Journal of Rheumatology · doi:10.1080/03009742.2025.2548704
“Hypersensitivity to pain and non-Table nociceptive sensory stimuli has long been recognized as a core symptom in fibromyalgia, and assessment of these clinical symptoms has been incorporated in the revised version of the Fibromyalgia Impact Questionnaire (FIQ-R) since 2009 (33).”
Evaluation of sarcopenia in female patients with fibromyalgia syndrome: an ultrasonographic approach
Karvanli, S., Karaköse, S., & Uğurlu, H. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1680355 · Cited by 3
Young, E. L., Atum, Y. V., Mista, C. A., Arévalo, D., Moglia, B., & Manresa, J. A. B. (2025) · medRxiv · doi:10.1101/2025.09.20.25336159
Akın, E., Saraçoğlu, İ., & Leblebicier, M. A. (2025) · Izmir Democracy University Health Sciences Journal · doi:10.52538/iduhes.1730818
Fatigue in fibromyalgia: a mental and physical context
Albuquerque, M. L. L., Álvarez, M. C., Neiva, H. P., Marinho, D. A., & Monteiro, D. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-24080-5.00024-2
Cognitive profiling in fibromyalgia patients using the MoCA
Yaka, E. C., & Özçete, Z. A. (2025) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-025-04120-1 · Cited by 1
“FM severity was quantified using the FM Impact Questionnaire (FIQ), a validated 10-item instrument assessing physical functioning, work status, depression, anxiety, sleep, pain, stiffness, fatigue, and well-being (0–100; higher scores denote greater impact) [18, 19].”
Psychometric evaluation of the Norwegian version of the Revised Fibromyalgia Impact Questionnaire
Provan, S. A., Hammer, H. B., & Kleppang, A. L. (2025) · Scandinavian Journal of Rheumatology · doi:10.1080/03009742.2025.2573532 · Cited by 1
“A revised questionnaire (FIQ-R) was published in 2009 by Bennett et al (7).”
InfluentialKarakoyun, A., Yılmaz, C. K., & Kasar, K. S. (2025) · Research in Nursing & Health · doi:10.1002/nur.70029 · Cited by 2
Locus Coeruleus MR Measured Signal Intensity in Fibromyalgia Relative to Healthy Controls
DeMayo, M. M., Cassidy, C., McCreary, C. R., Trang, T., Harris, A. D., & McGirr, A. (2025) · European Journal of Pain · doi:10.1002/ejp.70173
Biomarkers identification in fibromyalgia syndrome
Utzeri, S. (2013) · VEprints - Universita degli Studi di Cagliari
Maret, D., & Ledermann, K. (2025) · Cortica · doi:10.26034/cortica.2025.7025
Klemm, P., Becker, J., Aykara, I., Asendorf, T., Dischereit, G., Neumann, E., Müller-Ladner, U., & Lange, U. (2021) · Figshare · doi:10.6084/m9.figshare.13565778
Pontes-Silva, A., de Sousa, A. P., Dibai-Filho, A. V., de Souza, M. C., DeSantana, J. M., & Avila, M. A. (2023) · Figshare · doi:10.6084/m9.figshare.23354304
Rulleau, T., Planche, L., Etcheverrigaray, F., Dorion, A., Kacki, N., Miot, M., Liaigre, A., Ganem, Y., Schmidt, A., Taddéi, F., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12972090
Lazaridou, A., Paschali, M., Vilsmark, E. S., Wilkins, T., Napadow, V., & Edwards, R. (2022) · Figshare · doi:10.6084/m9.figshare.20208460
Rulleau, T., Planche, L., Etcheverrigaray, F., Dorion, A., Kacki, N., Miot, M., Liaigre, A., Ganem, Y., Schmidt, A., Taddéi, F., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12972087
Shepherd, H., Poliakoff, E., Brown, C. A., & Brown, R. J. (2025) · Journal of Pain Research · doi:10.2147/jpr.s551725
“26 This questionnaire measures the impact of fibromyalgia symptomatology in the past seven days.”
Pontes-Silva, A. (2026) · Clinical Rheumatology · doi:10.1007/s10067-025-07903-0 · Cited by 1
Harika‐Germaneau, G., Rannou, D., Charrier, E., Fairouqi, Y. E., Brunet, A., Doolub, D., Langbour, N., Raviart, I., Wassouf, I., & Jaafari, N. (2026) · Biomedicines · doi:10.3390/biomedicines14010190 · Cited by 2
“While fibromyalgia-specific instruments are often correlated with generic quality-of-life measures, it is important to distinguish between the original FIQ developed by Burckhardt et al. [25] and the revised FIQR published in 2009 by Bennett et al. [32].”
Sansone, C., Tenti, M., Carrozzino, D., Gremigni, P., & Casu, G. (2026) · Behavioral Sciences · doi:10.3390/bs16020259
“The Revised Fibromyalgia Impact Questionnaire (FIQR) The FIQR (Bennett et al., 2009) was developed to overcome the limitations of the Fibromyalgia Impact Questionnaire (FIQ; Burckhardt et al., 1991), the most used tool for evaluating FM patients.”
InfluentialOsorio, M. A. M., Ordoñez‐Mora, L. T., Mejía-Mejía, J., Román, F., López-Pérez, P. J., & Ramírez‐Vélez, R. (2026) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2026.02.006 · Cited by 1
Garncarz, K., Marek, A., Jamroch, K., Dziki, K., Dybizbańska, W., Nowakowska, Z., Burzej, A., Kacalak, M., Komenda, M., & Szklarska-Komenda, J. (2025) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.4(48).2025.4421
Randomized controlled trial of medical assistant-coached behavioral intervention for chronic pain
Hassett, A. L., Voepel‐Lewis, T., Zhu, G., Parks, A. C., Tsodikov, A., Long, J., Shaikh, S., Burgess, B., Brummett, C. M., Clauw, D. J., et al. (2026) · Regional Anesthesia & Pain Medicine · doi:10.1136/rapm-2025-107389
Pervaz, H., Rafique, A., Khan, H. H. I., Javed, R., Arif, S. A., Khaliq, S. S., Ghazanfar, S., & Ishfaq, A. (2026) · Cureus · doi:10.7759/cureus.105258
“Scores were computed and expressed on a 0-100 scale, with higher values indicating greater severity [13].”
Reducing Smartphone Addiction and Improving Fibromyalgia Outcomes: A Randomized Controlled Trial
Olcucu, N., & Muluk, S. Y. (2026) · Medical Records · doi:10.37990/medr.1767518
Albay, S., Salar, S., & Ekici, G. (2026) · American Journal of Occupational Therapy · doi:10.5014/ajot.2026.051431
“The FIQR is valid and reliable in the Turkish population (Bennett et al., 2009; Ediz et al., 2011).”
Post-publication corrections of rheumatology articles: a comprehensive analysis
Torun, B., & Kaya, E. (2026) · Revista Brasileira de Reumatologia · doi:10.1186/s42358-026-00537-z
Toussaint, L. L., Skalski‐Bednarz, S. B., Peck, T. L., Montesó‐Curto, P., & Mohabbat, A. B. (2026) · Pastoral Psychology · doi:10.1007/s11089-026-01320-z
“Although this distribution reflected the typical sex imbalance observed in fibromyalgia (clinically and scholarly) (Bennett et al., 2009), it did not allow for meaningful comparative analyses.”
Association Between Autonomic Symptoms and the Choroidal Vascularity Index in Fibromyalgia Patients
Zincirci, D. E., Yılmaz, İ. N., Atar, S., Demırhan, E., Arkan, İ., Karataş, G., Zincirci, M., Ferahman, D., & Kuru, Ö. (2026) · Medicina · doi:10.3390/medicina62040748
“The FIQ-R consists of 21 items across three domains (function, overall impact, and symptoms) and yields a total score from 0 to 100, with higher scores indicating greater overall impact of fibromyalgia on daily life [24].”
Bañuelos-Terés, L. E., Álvarez‐Gallardo, I. C., Gavilán‐Carrera, B., Segura‐Jiménez, V., Estévez‐López, F., Acosta‐Manzano, P., Carbonell‐Baeza, A., Delgado‐Fernández, M., & Ruiz, J. R. (2026) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2026.04.015
Hassan, A., Hussein, M., Magdy, R., Elgenidi, A., Merghany, N., Ismaeel, A. Y., Abdelghaffar, M., Yacoub, O., Fayez, M. M., Taha, N. A., et al. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1776543 · Cited by 1
Yi-hang, Y., Li, Y. P., Peng, M.-L., Zhang, G., Gao, K., Du, H.-F., Wang, M., Wu, X.-D., Xu, W., Chu, Y., et al. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1761852
“…pain index (WPI), symptom severity score (SSS) (Wolfe et al., 2010), revised Fibromyalgia Impact Questionnaire (FIQR) (Salaffi et al., 2023; Bennett et al., 2009), Fatigue Severity Scale (FSS) (Gencay-Can and Can, 2012), Insomnia Severity Index (ISI) (Calandre et al., 2022), Patient Health…”
Shrestha, N., Liu, M. M., 牛少宁, Cheng, H., Sun, Y., Mei, S., & Luo, F. (2026) · Journal of Pain Research · doi:10.2147/jpr.s598907 · Cited by 2
DeMayo, M. M., Sharifi, V., Chen, L., Zamponi, G. W., Trang, T., Harris, A. D., & McGirr, A. (2026) · Neuropsychopharmacology · doi:10.1038/s41386-026-02441-y
Durán‐González, E., Ramírez‐Tejero, J. A., Martín, I. S. M., Lora, A. T., Sánchez, M. P., Morano, R. G., Díaz-López, C., Martínez‐Lara, A., Díaz, M. A., & Marín, D. C. (2026) · Life · doi:10.3390/life16060894 · Cited by 1
DURUSOY, E., Ulusoy, A. İ., Zeyrek, Ö. Ö., Çetin, S. Y., Bilgin, S., & Ünal, E. (2026) · Healthcare · doi:10.3390/healthcare14121792 · Cited by 2
“The total score ranges from 0 to 100, with higher scores indicating greater disease impact [27].”
Patient Activation, Disease Burden, and Quality of Life in Women With Fibromyalgia
Shvartsur, R., Spektorman, M., Grosberg, D., Rudyk, I., & Magnezi, R. (2026) · Pain Management Nursing · doi:10.1016/j.pmn.2026.05.026
Gajda, R., & Jeżewska-Zychowicz, M. (2026) · Nutrients · doi:10.3390/nu18132081
“The functional status of individuals with fibromyalgia was assessed using the Revised Fibromyalgia Impact Questionnaire (FIQR) [27], based on the validated Polish version of the instrument (FIQ-Pol) [28].”
Future Orientation Scale: A Psychometric Evaluation Across Health-Vulnerable Samples
Altier, H. R., Sirois, F. M., Jeglic, E. L., & Hirsch, J. K. (2026) · Assessment · doi:10.1177/10731911261451782
Trunfio, F., Berardicurti, O., Bruni, R., Currado, D., Biticchi, B., Corberi, E., Saracino, F., Kun, L., Marino, A., Lamberti, L., et al. (2026) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x261421707
“22,23 The FAS-mod is a modified version of the original Fibromyalgia Assessment Status (FAS) questionnaire, developed in 2019.”
Behera, D., Jensen, M. P., Gopalakrishna, D. B., Patil, A., & Venkatesan, P. (2026) · International Journal of Clinical and Experimental Hypnosis · doi:10.1080/00207144.2026.2694420
Kim, J., Tusi, R., Tang, A. B., Kwasa, J. A. C., Kim, D., Forssell, M., Maurer, M., Rothe, D., Weber, D. J., Alter, B. J., et al. (2026) · Brain stimulation · doi:10.1016/j.brs.2026.103161
Çağlar, S. O., Hıra, S., & Çağlar, H. (2026) · Egyptian Rheumatology and Rehabilitation · doi:10.1186/s43166-026-00437-6
“The Fibromyalgia Impact Questionnaire Revised (FIQR) was used to evaluate physical function, overall impact, and symptom severity; the total score ranges from 0 to 100, with higher scores indicating greater disease impact [9].”
Dadakçi, Y. C. (2026) · Pain Research and Management · doi:10.1155/prm/4146674
“A 15-point between-group diference in FIQR change at 1 week was considered clinically meaningful [10, 11].”
Gajda, R., & Jeżewska-Zychowicz, M. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15155956
“Functional status in individuals with fibromyalgia was assessed using the Revised Fibromyalgia Impact Questionnaire (FIQR) [27], employing the validated Polish version of the instrument (FIQ-Pol) [28].”
Nielsen, M. J., Vægter, H. B., & Bruun, K. D. (2026) · Pain Management Nursing · doi:10.1016/j.pmn.2026.07.020
Harte, S. E., Arnold, L. M., Ichesco, E., Peltier, S., Cecil, K. M., Kaplan, C. M., Pluimer, B. R., Sridhar, A., Larkin, T. E., Schrepf, A., et al. (2026) · PAIN Reports · doi:10.1097/pr9.0000000000001489
Bianco, A., Russo, F., Prospero, L., Laselva, G., Grasso, M., D’Attoma, B., Verrelli, N., Ignazzi, A., Franco, I., Grazioli, E., et al. (2026) · Frontiers in Physiology · doi:10.3389/fphys.2026.1912788
Kung, L., Nhu, N. T., Yu, Y., Tsai, I., & Kang, J. (2026) · European Journal of Pain · doi:10.1002/ejp.70364
“We also used the Fibromyalgia Impact Questionnaire-Revised (FIQ-R), a 21-item instrument that assesses function, overall impact, and symptoms, with scores ranging from 0 to 100, where higher scores indicate a stronger impact of FM (Bennett et al. 2009).”
Pereira, B. M. D. S., Alencar, V. B., Azi, L. M. T. D. A., Kraychete, D. C., & Alves, R. L. (2026) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.61622/rbgo/2026rbgo49
Liu, M., Li, Y., 姚秀高, Liang, Y., Mao, P., Huang, Y., Zhang, C., Li, Y., Li, C., Ma, K., et al. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-110911
Hackshaw, K. V., Osuna-Diaz, M. M., Sebastian, K. R., Yu, L., Giusti, M. M., Mikulik, Z., & RODRIGUEZ‐SAONA, L. E. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2026.122431 · Cited by 1
Yu, L., Kioskli, K., Sibelli, A., & McCracken, L. M. (2026) · European Journal of Pain · doi:10.1002/ejp.70378
“The correlation between fibromyalgia symptom severity and functional impact of fibromyalgia was not examined, as the fibromyalgia symptom severity scores were derived from the measure of the functional impact of fibromyalgia (FIQ-R).”
InfluentialAssociations between anger and chronic primary pain : a systematic review and meta-analysis.
安達, 友., 榎本, 聖., Shibata, M., Adachi, T., Yamada, K., Fujino, H., & Enomoto, K. (n.d.) · Institutional Repositories DataBase (IRDB)
Auditory P300 as a neurophysiological marker of cognitive impairment in fibromyalgia syndrome
Osman, D., Sheta, S. M., Elsaid, N. Y., & ElDin, E. S. (2026) · The Egyptian Journal of Otolaryngology · doi:10.1186/s43163-026-01216-y
“Higher scores indicate greater disease burden and functional impairment [10, 11].”
Nuguri, S. M., RODRIGUEZ‐SAONA, L. E., Gao, C., Bao, H., Sebastian, K. R., Osuna-Diaz, M. M., Giusti, M. M., Yu, L., Castellví, S. D. L., & Hackshaw, K. V. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08919-z
Association of inflammatory indices with coronary artery calcium burden in fibromyalgia
Çağlar, S. O., Hıra, S., & Çağlar, H. (2026) · Medicine · doi:10.1097/md.0000000000050656
“[13] Pain intensity was rated on a 10-cm Visual Analog Scale (VAS), anchored at 0 for no pain and 10 for the most severe pain.”
Resilience and Family Factors in Fibromyalgia: Associations with Disease Severity and Impact
Altuntaş, V., Şahin, Z. D., & Muluk, S. Y. (2026) · Archives of Current Medical Research · doi:10.47482/acmr.1776296
Metadata
- Authors
- Bennett, R. M., Friend, R., Jones, K. D., Ward, R., Han, B. K., & Ross, R. L.
- Affiliations
- Oregon Health & Science University (US)
- Corresponding author
- Bennett, Robert M
- Venue
- Arthritis Research & Therapy
- Published
- 2009-08-10
- Volume
- 11
- Issue
- 4
- Pages
- R120-R120
- ISSN
- 1478-6354 (ISSN-L)
- PMC
- PMC2745803
- OpenAlex
- W2042116454
- Cited by
- 814
- References
- 28
- Citations by year
- 2026: 78 · 2025: 70 · 2024: 65 · 2023: 82 · 2022: 76 · 2021: 70 · 2020: 59 · 2019: 46 · 2018: 33 · 2017: 37 · 2016: 40 · 2015: 37 · 2014: 30 · 2013: 25 · 2012: 25
- FWCI
- 13.16
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/2.0/ (tdm)
- creativecommons.org/licenses/by/2.0/ (vor)
- Locations
- Arthritis Research & Therapy (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Fibromyalgia and Chronic Fatigue Syndrome Research
- Health Sciences › Health Professions › Physical Therapy, Sports Therapy and Rehabilitation › Musculoskeletal pain and rehabilitation
- Health Sciences › Medicine › Psychiatry and Mental health › Psychosomatic Disorders and Their Treatments
- Keywords
- fibromyalgia, Fibromyalgia Impact Questionnaire, patient-reported outcome measures, questionnaire validation, psychometric properties, SF-36, environmental sensitivity, tenderness, memory, balance, rheumatoid arthritis, systemic lupus erythematosus, major depressive disorder, scoring algorithm, discriminant validity
- MeSH terms
- Algorithms, Female, Fibromyalgia, Humans, Middle Aged, Psychometrics, Surveys and Questionnaires, Severity of Illness Index, Reproducibility of Results, Focus Groups
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.